FromBio is experiencing a strong early trading session after announcing a supply agreement with global distribution platform SiliconTwo for health supplements. This news has sparked optimism among investors regarding the company's expansion into international markets using SiliconTwo's distribution network.
As of 9:13 a.m. on the Korea Exchange, FromBio's shares were trading at 3,155 won, up 190 won (6.41%) from the previous trading day. The stock opened at 3,065 won and surged to 3,545 won in early trading before giving back some gains but maintaining its upward momentum.
Earlier, FromBio confirmed the supply agreement with SiliconTwo aimed at expanding its overseas market presence and distribution network.
Under this agreement, FromBio will supply 35 health supplement products, including its flagship items mastic and boswellia, through SiliconTwo's global distribution network for one year.
Additionally, FromBio plans to leverage SiliconTwo's distribution network, which spans over 170 countries, along with its online and offline sales channels and marketing infrastructure, to target key distribution networks in various countries and implement tailored marketing strategies for different markets.
FromBio stated that this agreement will enhance its localization strategy in major markets, including North America, Europe, Japan, and Southeast Asia.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.